Of the roughly 1.5 million adverse drug events are reported annually to the FDA, more than half are attributed to infusion-related errors. The automated pumps that ...

The U.S. Food and Drug Administration has announced a new initiative to address safety problems associated with external infusion pumps, which are often used to deliver fluids, including nutrients and ...

Federal regulators say they are moving to tighten their oversight of medical devices, including one of the most ubiquitous and problematic pieces of medical equipment — automated pumps that ...

The global infusion pump market is projected to grow at a compound annual growth rate (CAGR) of approximately 8% over the forecast period. Key factors driving this growth include the rising prevalence ...

Data shared in collaboration with The University of Texas Medical Branch, representing an analysis of more than one million intravenous (IV) infusions using Baxter’s Spectrum IQ large volume infusion ...

The objective of this study was to evaluate the accuracy, reliability, safety, and efficacy of the Codman Model 3000 Constant Flow Implantable Infusion Pump for intrathecal baclofen delivery as a ...

The infusion pumps market is expected to grow significantly, with a projected valuation of US$ 641.7 million by 2023. The market exhibits a noteworthy pattern, with a compound annual growth rate (CAGR ...

Climate Change and Cancer Care: A Policy Statement From ASCO Hepatic artery infusion (HAI) delivers localized high-dose floxuridine directly to liver tumors through an implanted pump. While patients ...

DEERFIELD, Ill., December 11, 2025--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced data in collaboration with The ...